Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy.
BACKGROUND
The spectrum of ocular indications in which intravitreal injections of triamcinolone acetonide may be therapeutically useful has recently been expanding.


METHODS
Prospective clinical interventional case study in a young adult male with florid proliferative diabetic retinopathy (FPDR).


RESULTS
A greater reduction of retinal thickening and fluorescein leakage from retinal new vessels was observed in the right eye after intravitreal injection of triamcinolone followed by scatter panretinal photocoagulation (PKP) than in the left eye treated only by laser.


CONCLUSIONS
Intravitreal injection of triamcinolone acetonide may be a useful adjunct to scatter panretinal photocoagulation for FPDR.
Bandello
Francesco
F
Department of Ophthalmology, University of Udine, 33100 Udine, Italy. francesco.bandello@uniud.it
Pognuz
Derri Roman
DR
Pirracchio
Angelo
A
Polito
Antonio
A
D000328:Adult; D001813:Blood-Retinal Barrier; D002199:Capillary Permeability; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000601:surgery; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation; D008297:Male; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide